Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling

Drug Des Devel Ther. 2023 Dec 24:17:3803-3831. doi: 10.2147/DDDT.S443462. eCollection 2023.

Abstract

Dysregulation of the gut microbial ecosystem (GME) (eg, alterations in the gut microbiota, gut-derived metabolites, and gut barrier) may contribute to the onset and progression of extra-intestinal diseases. Previous studies have found that Traditional Chinese Medicine herbs (TCMs) play an important role in manipulating the GME, but a prominent obstacle in current TCM research is the causal relationship between GME and disease amelioration. Encouragingly, co-housing and fecal microbiota transplantation (FMT) provide evidence-based support for TCMs to treat extra-intestinal diseases by targeting GME. In this review, we documented the principles, operational procedures, applications and limitations of the key technologies (ie, co-housing and FMT); furthermore, we provided evidence that TCM works through the GME, especially the gut microbiota (eg, SCFA- and BSH-producing bacteria), the gut-derived metabolites (eg, IS, pCS, and SCFAs), and intestinal barrier to alleviate extra-intestinal diseases. This will be beneficial in constructing microecological pathways for TCM treatment of extra-intestinal diseases in the future.

Keywords: TCM herb; co-housing; extra-intestinal disease; fecal microbiota transplantation; gut microbial ecosystem.

Publication types

  • Review

MeSH terms

  • Fecal Microbiota Transplantation / methods
  • Gastrointestinal Microbiome* / physiology
  • Housing
  • Humans
  • Intestinal Diseases* / drug therapy

Grants and funding

This research was funded by National Natural Science Foundation of the People’s Republic of China (grant number 82174295).